These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 217536)

  • 1. New side effect of the hypoxic cell sensitizer, misonidazole.
    Partington J; Koziol D; Chapman D; Rabin H; Urtasun RC
    Cancer Treat Rep; 1979 Jan; 63(1):123-5. PubMed ID: 217536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole.
    Saunders MI; Dische S; Kogelnik HD; Sealy R; Lenox-Smith I
    Cancer Treat Rep; 1980; 64(2-3):263-8. PubMed ID: 6447539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y
    Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences with the radiation-sensitizing agent misonidazole].
    Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
    Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
    [No Abstract]   [Full Text] [Related]  

  • 5. Misonidazole in the clinic at Mount Vernon.
    Dische S
    Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
    Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
    Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD
    Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD; Strike TA
    Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M; Tamulevicius P; Streffer C; Scherer E
    Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials of misonidazole in the United States.
    Wasserman TH; Stetz J; Phillips TL
    Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.
    Kogelnik HD; Meyer JH; Jentzsch K; Szepesi T; Kärcher KH; Maida E; Mamoli B; Wessely P; Zaunbauer F
    Br J Cancer Suppl; 1978 Jun; 3():281-5. PubMed ID: 209810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H; Watarai J; Hoshino T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
    Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H; Calcanis A; Godehardt E; Weidtman V; Zülch KJ; Ammon J; Bamberg M; Herbst M; Keim H; Kleibel F; Makoski HB; Potthoff PC; Schlegel G; Schnepper E
    Strahlentherapie; 1982 Aug; 158(8):466-9. PubMed ID: 6753245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic transformations in vitro produced by misonidazole.
    Miller RC; Hall EJ
    Cancer Clin Trials; 1980; 3(1):85-90. PubMed ID: 7389040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration of misonidazole and peripheral neuropathy.
    Marten TR
    Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development of new hypoxic cell radiosensitizer in Japan].
    Mori T; Murayama C
    Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with daily doses of misonidazole (author's transl)].
    Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
    Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.